DiscoverThe Tell-Tale Heart: The Pharmacist's Cardiovascular Digest10: COBRRA Trial Results Raise Questions About VTE Management
10: COBRRA Trial Results Raise Questions About VTE Management

10: COBRRA Trial Results Raise Questions About VTE Management

Update: 2025-07-15
Share

Description

This week, host Craig Beavers sat down with Tara Lech, PharmD, CACP, director of anticoagulation services at Beth Israel Lahey Health, to discuss recent findings from the COBBRA trial, which compared bleeding risk with rivaroxaban versus apixaban.
Comments 
In Channel
15: ESC 2025 Highlights: Insights on ALONE-AF and AQUATIC Trials

15: ESC 2025 Highlights: Insights on ALONE-AF and AQUATIC Trials

2025-09-0942:16

14: Sifting Through Discordant Data From ESC 2025

14: Sifting Through Discordant Data From ESC 2025

2025-09-0550:17

13: From Guidelines to Action: Pharmacy’s Role in Hypertension Management

13: From Guidelines to Action: Pharmacy’s Role in Hypertension Management

2025-08-2640:40

12: A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025

12: A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025

2025-08-1227:04

11: A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

11: A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

2025-07-2901:06:24

10: COBRRA Trial Results Raise Questions About VTE Management

10: COBRRA Trial Results Raise Questions About VTE Management

2025-07-1531:46

9: An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial

9: An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial

2025-07-0144:50

8: Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

8: Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

2025-06-1741:07

7: New Programs Aim to Improve Implementation of Cardiovascular Interventions

7: New Programs Aim to Improve Implementation of Cardiovascular Interventions

2025-06-0253:04

6: Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial

6: Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial

2025-05-2040:36

5: Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

5: Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

2025-05-0639:10

4: The RIVAWAR Trial and ACS Guidelines for LV Thrombus

4: The RIVAWAR Trial and ACS Guidelines for LV Thrombus

2025-04-2239:02

3: Updates to Acute Coronary Syndrome Guidelines

3: Updates to Acute Coronary Syndrome Guidelines

2025-04-0836:52

2: Everything You Need to Know from the American College of Cardiology 2025 Scientific Session

2: Everything You Need to Know from the American College of Cardiology 2025 Scientific Session

2025-04-0101:20:05

1: Introducing the Tell-Tale Heart Podcast

1: Introducing the Tell-Tale Heart Podcast

2025-03-2504:21

Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

10: COBRRA Trial Results Raise Questions About VTE Management

10: COBRRA Trial Results Raise Questions About VTE Management

The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest